Zhao‐Ru Dong

2.4k total citations
87 papers, 1.1k citations indexed

About

Zhao‐Ru Dong is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Zhao‐Ru Dong has authored 87 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 28 papers in Cancer Research and 25 papers in Molecular Biology. Recurrent topics in Zhao‐Ru Dong's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Zhao‐Ru Dong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Zhao‐Ru Dong collaborates with scholars based in China, Ethiopia and Sweden. Zhao‐Ru Dong's co-authors include Tao Li, Lun‐Jie Yan, Zhiqiang Chen, Zi‐Niu Ding, Ai‐Wu Ke, Yu‐Chuan Yan, Jia Fan, Guo‐Ming Shi, Xu–Ting Zhi and Jian‐Guo Hong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Zhao‐Ru Dong

78 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhao‐Ru Dong China 21 442 346 318 236 221 87 1.1k
Xiaokun Ma China 18 355 0.8× 358 1.0× 281 0.9× 212 0.9× 292 1.3× 70 1.1k
Naoto Kubota Japan 14 573 1.3× 336 1.0× 231 0.7× 229 1.0× 183 0.8× 38 1.3k
Qi‐Man Sun China 18 470 1.1× 298 0.9× 397 1.2× 180 0.8× 104 0.5× 37 1.0k
Chen Huang China 16 326 0.7× 271 0.8× 214 0.7× 133 0.6× 85 0.4× 38 843
Annalisa Altimari Italy 20 380 0.9× 389 1.1× 255 0.8× 109 0.5× 158 0.7× 72 1.1k
Kota Arima Japan 19 259 0.6× 644 1.9× 260 0.8× 128 0.5× 231 1.0× 71 1.1k
Anand S. Merchant United States 18 465 1.1× 327 0.9× 149 0.5× 146 0.6× 82 0.4× 24 1.0k
Klaus J. Schmitz Germany 22 514 1.2× 401 1.2× 297 0.9× 184 0.8× 147 0.7× 51 1.4k
Lijian Liang China 23 529 1.2× 489 1.4× 325 1.0× 407 1.7× 262 1.2× 74 1.4k
Anne‐Christine Piguet Switzerland 13 303 0.7× 321 0.9× 115 0.4× 272 1.2× 211 1.0× 24 923

Countries citing papers authored by Zhao‐Ru Dong

Since Specialization
Citations

This map shows the geographic impact of Zhao‐Ru Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao‐Ru Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao‐Ru Dong more than expected).

Fields of papers citing papers by Zhao‐Ru Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao‐Ru Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao‐Ru Dong. The network helps show where Zhao‐Ru Dong may publish in the future.

Co-authorship network of co-authors of Zhao‐Ru Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao‐Ru Dong. A scholar is included among the top collaborators of Zhao‐Ru Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao‐Ru Dong. Zhao‐Ru Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2025). An umbrella review of the association between dietary factors and hepatocellular carcinoma risk. Food & Function. 16(10). 3879–3890.
3.
Hou, Shuang, Hao Tang, Zhao‐Ru Dong, & Wence Zhou. (2025). eIF6: a promising therapeutic target for gastric carcinoma via PI3K/AKT pathway modulation. World Journal of Surgical Oncology. 23(1). 113–113.
4.
Dong, Zhao‐Ru, et al.. (2025). FAM60A promotes proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin signaling pathway. Translational Cancer Research. 14(2). 1171–1189.
5.
Tan, Siyu, Pan Guoqiang, Lun‐Jie Yan, et al.. (2024). DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression. Cell Death and Disease. 15(7). 540–540. 5 indexed citations
6.
Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2024). Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 39(8). 1464–1475. 2 indexed citations
7.
8.
Xu, Bowen, Wei Zhao, Jianhua Chang, et al.. (2023). Comparative study on left-sided versus right-sided hepatectomy for resectable peri-hilar cholangiocarcinoma: a systematic review and meta-analysis. World Journal of Surgical Oncology. 21(1). 153–153. 5 indexed citations
9.
Yan, Lun‐Jie, Yu‐Chuan Yan, Zi‐Niu Ding, et al.. (2023). Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis. European Journal of Cancer. 185. 150–163. 8 indexed citations
10.
Chen, Xiong, Lun‐Jie Yan, Yu‐Chuan Yan, et al.. (2023). Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 149(18). 16869–16884. 1 indexed citations
11.
Yang, Chuncheng, et al.. (2022). The causal relationship between white blood cell counts and hepatocellular carcinoma: a Mendelian randomization study. European journal of medical research. 27(1). 278–278. 12 indexed citations
12.
Han, Cheng‐Long, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2022). The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 827788–827788. 27 indexed citations
13.
Ding, Zi‐Niu, Zhao‐Ru Dong, Zhiqiang Chen, et al.. (2021). Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis. Journal of Gastroenterology and Hepatology. 36(6). 1487–1496. 6 indexed citations
14.
15.
Dong, Zhao‐Ru, Zhiqiang Chen, Xiaoyun Yang, et al.. (2021). RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival. Journal of Cancer. 12(13). 3827–3840. 10 indexed citations
16.
Ding, Zi‐Niu, Zhao‐Ru Dong, Zhiqiang Chen, et al.. (2021). Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis. Frontiers in Immunology. 12. 733530–733530. 26 indexed citations
17.
Liu, Yang, et al.. (2020). Therapeutic management of isolated internal iliac artery aneurysms. Journal of Vascular Surgery. 72(6). 1968–1975. 8 indexed citations
18.
Sun, Shaoyang, Jingjing Wang, Fei Fei, et al.. (2018). Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult. Cancer Research. 78(19). 5548–5560. 46 indexed citations
19.
Dong, Xiaofeng, Tianqi Liu, Xu–Ting Zhi, et al.. (2018). COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment. Clinical Cancer Research. 24(13). 3204–3216. 70 indexed citations
20.
Dong, Zhao‐Ru, Dong Sun, Guo‐Ming Shi, et al.. (2017). Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis. Journal of Cancer. 8(18). 3862–3867. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaokun Ma Breakdown of academic impact, for papers by Naoto Kubota Breakdown of academic impact, for papers by Qi‐Man Sun Breakdown of academic impact, for papers by Chen Huang Breakdown of academic impact, for papers by Annalisa Altimari Breakdown of academic impact, for papers by Kota Arima Breakdown of academic impact, for papers by Anand S. Merchant Breakdown of academic impact, for papers by Klaus J. Schmitz Breakdown of academic impact, for papers by Lijian Liang Breakdown of academic impact, for papers by Anne‐Christine Piguet
Rankless by CCL
2026